TAYLOR MOO-YOUNG: Open Payments
NPI 1871372979 · NORTH CHESTERFIELD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,301 in 164 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $2,844 · 2025 $3,301
Food & beverage: $3,301
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $643 |
| Takeda Pharmaceuticals U.S.A., Inc. | 45 | $554 |
| Janssen Biotech, Inc. | 26 | $537 |
| QOL Medical, LLC | 9 | $262 |
| GENZYME CORPORATION | 7 | $220 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $207 |
| Madrigal Pharmaceuticals | 5 | $171 |
| Ardelyx, Inc. | 9 | $155 |
| Ipsen Biopharmaceuticals, Inc | 6 | $134 |
| PFIZER INC. | 6 | $126 |
Products named: TREMFYA, ENTYVIO, Sucraid, DUPIXENT, SKYRIZI, XIFAXAN, RINVOQ, EOHILIA.
Industry payments across VA — which companies pay providers there.
